Portfolio Management Services (PMS)
Compare Schemes

Dezerv Equity Revival Strategy vs Valcreate Lifesciences and Specialty Opportunities

Dezerv Equity Revival Strategy
Valcreate Lifesciences and Specialty Opportunities
Add Scheme
Return for the risk
3 yrs return
5%
10%
15%
20%
25%
Nifty 500 · 12.1%
10%
20%
30%
Volatility • 3 yrs deviation
1 Month
0.80%
6.35%
6 Months
2.16%
17.95%
1 Year
5.26%
21.71%
3 Years
13.42%
19.34%
5 Years
—
—
Since Inception
16.57%
19.34%
Fund Age
4 yrs 4 mo
3 yrs 6 mo
AUM
₹7,112.14 Cr
₹18.73 Cr
Alpha – 1 Year
0.54%
16.99%
Alpha – 3 Years
1.33%
7.25%
Information Ratio – 3 Years
—
0.85
Volatility – 1 Year
—
22.22%
Volatility – 3 Years
—
20.72%
Beta – 1 Year
—
0.87
Beta – 3 Years
—
0.89
Sharpe Ratio – 1 Year
—
0.75
Sharpe Ratio – 3 Years
—
0.85
Worst Rolling Year
—
—
Value at Worst Rolling Year
—
—
Deepest Drawdown
—
—
Recovery Period
—
—
1-Year Rolling Windows Positive
—
—
Median Rolling Year
—
—
5-Year Rolling Windows Positive
—
—
Market-Cap Mix
—
—
Number of Stocks
—
—
Portfolio P/E
—
—
Top 5 Holdings
—
Sharda Cropchem Ltd · 11.13%
Kwality Pharmaceuticals Ltd · 5.72%
Sumitomo Chemical India Ltd · 5.72%
Vinati Organics Ltd · 5.51%
Rallis India Ltd · 5.34%
Top Sectors
—
—
Fixed Fee
1.00% / yr
2.50% / yr
Performance Fee / Plan
10% of profit
Fixed Plan
Exit Load (Y1 / Y2 / Y3)
0% / 0% / 0%
0% / 0% / 0%
Let's start a
conversation
  • Compare this PMS against 3,000+ others with our research desk
  • Build a long-term portfolio around your goals, not a one-off buy
  • Experts with decades of experience.
Private. Personal. No obligation.
We will only use these details to contact you about this enquiry. No spam.
Start a conversation
Share a few details and an expert will reach out.
We will only use these details to contact you about this enquiry. No spam.